Aims The colorectal Clinical Nurse Specialist (CNS) makes an important contribution to the care of individuals diagnosed with a significant polyp and early colorectal cancer (SPECC).
Introduction
The colorectal Clinical Nurse Specialist (CNS) contributes to the care of individuals diagnosed with a significant polyp and early colorectal cancer (SPECC). A key CNS function is to support the patient through the diagnostic and treatment pathway both directly through face-to-face and telephone contact and indirectly by acting as their advocate at any multidisciplinary team (MDT) meetings. A CNS can offer personalized information to improve patients' understanding of their diagnosis, to help them make choices about their available treatment options and to prepare them for any treatment undertaken [1] . By remaining respectful of, and responsive to, individual preferences, needs and values, the patient will be put at the centre of decisions to get the best outcome. This paper adds new insights to the literature by explaining the different facets of the CNS role for this patient group.
Explaining terminology
Whilst the concept of a polyp is generally understood by most people, the term 'significant' polyp might be open to misinterpretation. It is worth eliciting the patient's current understanding of their diagnosis and explaining that a significant polyp is one which is generally large (> 20 mm), likely to be sessile, unusual in appearance and/or difficult to access and remove endoscopically [2] . The CNS can highlight that this type of polyp indicates a requirement for careful treatment planning and possibly specialist management -if it proves to be cancerous.
Polyps can be in the form of a small 'cherry-like' swelling on a stalk (pedunculated), but they may also be flat or slightly raised lesions (sessile). Illustrations of polyp classifications used such as Kikuchi [3] and the Haggitt classification [4] and/or the formal staging systems such as TNM and even the adenoma to carcinoma sequence should be offered. Visual information can help individuals assimilate the difference between the degrees of dysplasia and the implications of each with respect to risk of malignancy.
In this evolving and highly technical speciality, there are also several frequently spoken acronyms for the treatment of these conditions including endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR) and transanal endoscopic surgery (TEMS), so it is important that all terminology is explained and reinforced by relevant written information (see Appendix S1).
Emotional support
Established guidance recommends that a nurse is present when a patient is informed of their cancer diagnosis [5, 6] . Several nurses may be involved at this stage: a nurse endoscopist, the endoscopy nurse assistant, or it may be a nurse specializing in colorectal cancer. To date, we only know of one Polyp Nurse Specialist in the UK, a core member of a polyp MDT whose role includes overseeing the care of any patient with a significant polyp.
In the case of SPECC, involvement of a specialist nurse is advised to provide emotional support to those patients who have been told they have a polyp or lesion in the colon or rectum which is highly suggestive or suspicious of cancer. In cases when the endoscopist believes the polyp does not look typically like a cancerous polyp but nevertheless deems that the lesion displays one or more suspicious features requiring further analysis, such input may not be needed.
Patient reactions to a possible diagnosis of colorectal cancer will need to be assessed on an individual basis and reassessed when a confirmed diagnosis is made. Some individuals will not be unduly alarmed by the possibility that the detected polyp may contain cancerous cells. Others will be so shocked to hear the word 'cancer' mentioned that their only thought will be whether they are going to survive [7] .
A confirmed diagnosis of colorectal cancer may engender many fears and anxieties [8] . The CNS in cancer care can encourage expression of emotions and concerns, as well as providing appropriate information as questions arise. The combination of time, compassion and skilled communication is invaluable in helping patients make sense of their situation and engage in treatment decision-making.
Communicating treatment options
Treatment pathways for a significant polyp can be complex due to factors such as the position of the polyp in the colon or rectum, e.g. if it is partly hidden in a fold of bowel. The patient should be reassured in such circumstances that it is good practice not to try to remove the polyp at this time but for the endoscopist to reassess, arrange subsequent tests and then discuss management options with them before proceeding. Whilst a delay in treatment may initially cause frustration (especially when full bowel preparation has been administered), explanation should allay concerns. In other cases, when the polyp has an appearance which looks more likely to be a cancer, the management strategy may be communicated with more confidence.
Whatever the pathway, the CNS can inform the patient about the next steps of their care and likely time scales involved, e.g. that it will take at least 5-7 days before any histology results are ready. The patient must leave the endoscopy unit with a clear plan of how their results will be communicated to them and with key contact numbers. They should be prepared for the probable requirement for more investigations and the possibility of being referred to another specialist centre for their treatment. Since patients have usually received sedation during their endoscopy, they may not recall much, or all, of a conversation. Ideally, any significant news will be delivered in the presence of a relative or friend (with the patient's permission). Written information and contact details of the CNS must also be provided.
Treatment decision-making
Many patients will look to their treating team to help guide their decision-making. We know some people will want as much information as possible, as part of their coping strategy, whilst others will choose not to actively participate and opt to let their medical team decide [9] .
Information seekers may seek clarification from the CNS on the significance of features such as the presence of lymphatic or vascular invasion and the depth of the cancer in the bowel wall. For example, if there is still cancer at the base of the scar on the bowel, further excision and treatment will be needed. The MRI or endoanal ultrasound report may provide valuable details about the polyp which can be shared with the patient to inform treatment decision-making (Table 1) .
If a colorectal cancer diagnosis is confirmed, there are some key factors which should be considered (Table 2) . With these facts in mind, decision aids can be offered to help individuals appraise the relative risks and benefits of the options available to them. Some key questions which can elicit treatment preferences include the following. For individuals contemplating a bowel resection, the risks associated with having a major operation need to be understood alongside appreciating that colorectal cancer surgery offers reliable clinical outcomes. Any surgery on the colon and rectum, whether performed as an open operation or laparoscopically, should be considered carefully with the surgical team. Individuals may focus initially on what it means for them in the short term, i.e. how quickly they can have the surgery and how long their initial recovery will be, rather than any more lasting consequences [10] . Yet it is important that they are aware that after a bowel resection there may be changes in bowel, urinary and sexual function and altered body image. Nurses are ideally placed to initiate discussion not just of the acute effects but the longer-term issues and the potential for a reduction in quality of life for months, or years, afterwards [11] .
A key role for the CNS during treatment decisionmaking is remaining highly sensitive to an individual's preferences and priorities. Active listening and empathy are therefore essential communication skills. The CNS should convey to the rest of the MDT what matters most to that individual so that the relative acceptability and appropriateness of proposed treatments can be discussed, and patient-centred care promoted [12, 13] . A CNS is likely to know the patient's preferences, values and expressed needs better than anyone else in the team [14, 15] . They must also encourage discussion of patients' comorbidities, performance status and psychosocial circumstances which can also impact on the proposed management plan. By being an active presence in an MDT, the CNS will improve the quality of the decision-making [16] .
The CNS role and impact upon patient experience
Patient experience is increasingly regarded as a key outcome of cancer care. In England, the current national cancer strategy emphasizes the importance of considering the care experience of patients with cancer 'on a par with clinical effectiveness and safety'. Whilst the predictors of positive or negative patient experience are poorly understood, we do know that patients generally prefer a consultation style that is open and informative, which offers them the chance to participate and feel a partner in their care [17] . It is also asserted that establishing such rapport engenders trust in the treating team [18] .
Most patients wish to quickly proceed to treatment and can find it frustrating when there is a need for another investigation or consultation. They may perceive this as a treatment delay unless the rationale is carefully explained. The CNS can help to expedite care by liaising across specialities and creating space in the system. They also provide continuity in the patient journey which can be important not just during treatment but in the surveillance planned after treatment. The CNS may well need to coordinate such follow-up, particularly if other hospitals are involved. Table 1 Information a patient may want to know about their polyp to inform treatment decision-making.
The shape and type of polyp The diameter and thickness of polyp (millimetres) If the polyp has a stalk, the stalk's diameter and thickness If there is a stalk, does it look to be invaded by the tumour? How much of the stalk appears preserved? The width of the portion of the polyp that appears attached or invades into the bowel wall The degree of preservation measured in millimetres of the bowel lining (submucosa), muscle layer at the area of the polyp that appears to be attached or invading The border and appearance of lymph nodes (not their size) to assess risk of malignancy The height of the polyp in relation to the anus (anal verge and anal sphincter) An evaluation for spread of tumour which could be directly from the polyp close to the bowel wall or away from the bowel in the surrounding fatty tissues Source: SPECC collaborative. • Where the cancer is in the bowel The latest findings of the national cancer patient experience survey for 2017 [19] indicate that nearly all cancer patients (91% of respondents) are given the name of a CNS who can support them through their treatment. However, the CNS census reveals there is a variation in colorectal cancer CNS caseloads from 48 to 150 new patients a year. Of the total colorectal cancer CNS workforce (435 posts across the UK), a third (34%) are working below a Band 7; more than two-thirds have a specialist cancer qualification (77%), advanced communication skills (81%) and teaching qualification (65%). This creates disparity in service provision and possibly therefore patient experience.
Evidence from national cancer surveys indicates that, by having access to a CNS, patients' cancer experiences are better coordinated, leading to enhanced care outcomes [19] . The CNS contribution can improve the overall quality and effectiveness of patients' cancer management [19, 20] . High workload pressures and downgrading of specialist roles to a Band 6 should be addressed nationally to ensure patients have access to recommended standards of care and receive the support they need.
Conclusion
A key aspect of the CNS role when a patient is diagnosed with a SPECC is to offer support and information to ensure patients make the right decisions for them about their care. Treatment decisions are crucial as they impact not only on a patient's survival but also on their quality of life. It is important that the decisionmaking process is open and informative and offers patients the chance to participate. We know patients want to be informed and involved but they may not necessarily want to make the final treatment choice. Detailed explanation of the relative benefits vs risks of the treatment options being proposed requires expert communication skills, specialist knowledge and a patient-centred approach. CNSs can personalize the care pathway by eliciting individual treatment preferences, acting as a patient advocate and expediting any tests and appointments required to achieve a timely and appropriate treatment plan.
